• Publications
  • Influence
Durability of response to vaccination against viral hepatitis A in HIV-infected patients: a 5-year observation
TLDR
It is demonstrated that most of the studied HIV-positive patients were susceptible to hepatitis A virus infection and most HIV-infected adults with high CD4 counts had a durable response even up to 5 years after vaccination.
Coordinated increase of miRNA-155 and miRNA-196b expression correlates with the detection of the antigenomic strand of hepatitis C virus in peripheral blood mononuclear cells.
TLDR
This study demonstrates that HCV RNA replication in PBMCs of chronic hepatitis C patients is connected with the increased and coordinated expression of mi RNA-155 and miRNA-196b.
[The comparison of the humoral response among the patients with liver cirrhosis and steatosis of the liver after HBV vaccination].
TLDR
Patients suffering from the liver cirrhosis responded much less favorably to the hepatitis B vaccine than patients with the liver steatosis, and the HBV vaccine was observed in the patients with liver Steatosis.
Immunogenicity of Inactivated Hepatitis A Vaccine in Children With Chronic Liver Disease
TLDR
One and 6 months after vaccination with hepatitis A virus vaccine (HAVRIX 720 Junior) in children with chronic hepatitis C infection seroprotection were 92% and 75% at both times.
Effect of interferon alfa and ribavirin treatment on hepatitis C virus RNA in serum and peripheral blood mononuclear cells in children with chronic hepatitis C.
TLDR
Age and gender, infection route, history of HBV infection or severity of histopathologic liver lesions had no influence on the efficacy of treatment with IFN-alpha and ribavirin, and clearance of HCV from serum and from PBMC occurs less frequently in patients previously resistant to IFNs.
[Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report)].
TLDR
The overall SVR achieved in this predominantly genotype 1 population was 55.7%, and rates were significantly higher in treatment-naïve patients, those with non-1 genotypes, and in patients with lower baseline fibrosis scores.
Reactive oxygen intermediates and serum antioxidative system in patients with chronic C hepatitis treated with IFN-alpha and thymus factor X.
TLDR
Increased in vitro reactive oxygen species production by both stimulated and unstimulated peripheral blood neutrophils of patients with CCH was observed and a statistically significant increase in the serum antioxidant capacity was observed, which suggests the induction of compensatory processes.
...
...